Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lars Sörén is active.

Publication


Featured researches published by Lars Sörén.


Scandinavian Journal of Infectious Diseases | 1989

A New Diagnostic Approach to the Patient with Severe Pneumonia

Jan Sörensen; Pia Forsberg; Erik Håkanson; Rolf Maller; Christer Sederholm; Lars Sörén; Christer Carlsson

36 patients with severe community-acquired pneumonia, treated in an intensive care unit (ICU), were examined in a prospective study using a comprehensive diagnostic program to establish an early etiological diagnosis. The resulting prompt and adequate antimicrobial therapy may have decreased the number of fatal cases. Special emphasis was placed on the use of a method incorporating fiberoptic bronchoscopy, together with protected brush sampling and bronchial lavage. An etiological diagnosis was established in 81% (29/36) of the cases. This etiological diagnosis was established within 48-72 h in 53% (19/36) of the patients, S. pneumoniae being the most frequent agent found (12 patients). This information, however, was poorly utilized since in only 11/19 of these patients was the antimicrobial therapy changed from a broad-spectrum antibiotic to a more specific narrow spectrum agent. The overall mortality rate was 22% (8/36). 7/8 patients who died had compromising factors. Most deaths in community-acquired pneumonia are still associated with pneumococcal infection. We conclude that fiberoptic bronchoscopy with brush samples via a plugged double lumen catheter provides the least misleading information concerning the etiological agent in pneumonia; sampling should be done as soon as possible after admission to the hospital, ideally before the need for ICU treatment; factors other than prompt antimicrobial therapy may influence the outcome of severe community-acquired pneumonia.


Acta Anaesthesiologica Scandinavica | 1999

Surveillance of antibiotic resistance in ICUs in southeastern Sweden

C.‐M. Erlandsson; Håkan Hanberger; I. Eliasson; Mikael Hoffmann; Barbro Isaksson; S. Lindgren; Lennart E. Nilsson; Lars Sörén; Sten Walther

Background: A study was designed to assess a computer‐based program for continuous registration of antibiotic resistance, statistics concerning severity of illness, and consumption of antibacterial drugs.


Acta Pathologica Microbiologica Scandinavica Section C Immunology | 2009

IN VITRO EFFECTS OF RUBELLA VIRUS, STRAIN RA 27/3, ON HUMAN LYMPHOCYTES

Rolf Maller; Lars Sörén

Investigation has been made of the specific in vitro stimulation of human lymphocytes by live or inactivated rubella virus of the strain RA 27/3. The thymidine incorporation of lymphocytes from blood donors with different serological immunity against rubella was measured following incubation with the viral antigens. UV-inactivated rubella virus caused a moderate degree of stimulation of lymphocytes from seropositive individuals. On the other hand, live rubella virus stimulated lymphocytes from donors with low titres of anti-rubella HI-antibodies but not lymphocytes from donors with high antibody titres. Possible explanations for this discrepancy are discussed.


Journal of Antimicrobial Chemotherapy | 1988

Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method

Barbro Isaksson; Lennart Nilsson; Rolf Maller; Lars Sörén


Journal of Antimicrobial Chemotherapy | 1988

A study of amikacin given once versus twice daily in serious infections

Rolf Maller; Barbro Isaksson; Lennart E. Nilsson; Lars Sörén


Journal of Antimicrobial Chemotherapy | 1999

New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units

Håkan Hanberger; Lennart E. Nilsson; B Claesson; A Kärnell; P Larsson; M Rylander; Erik Svensson; Mikael Sörberg; Lars Sörén


Journal of Antimicrobial Chemotherapy | 1987

Frequencies of variants resistant to different aminoglycosides in Pseudomonas aeruginosa

Lennart Nilsson; Lars Sörén; Gunilla Rådberg


Journal of Antimicrobial Chemotherapy | 1986

Selective growth of resistant variants during incubation of Enterobacteriaceae with four aminoglycosides

Lennart Nilsson; Lars Sörén


Journal of Antimicrobial Chemotherapy | 1992

Frequencies of subpopulations of aminoglycoside- and vancomycin-resistant variants in Staphylococcus aureus and Staphylococcus epidermidis

G. Rädberg; Lennart E. Nilsson; E. Kihiström; Rolf Maller; Lars Sörén


Acta Pathologica Microbiologica Scandinavica Section C Immunology | 2009

IN VITRO EFFECTS OF RUBELLA VIRUS, STRAIN RA 27/3, ON HUMAN LYMPHOCYTES:: I. Viral Inhibition of Mitogen Stimulation in Relation to Rubella Haemagglutination Inhibition Antibodies

Rolf Maller; Lars Sörén

Collaboration


Dive into the Lars Sörén's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Erik Svensson

Sahlgrenska University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge